FUMAGALLI, ELENA
FUMAGALLI, ELENA
Universita' degli Studi di MILANO
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
2022 B. Vincenzi, A. Napolitano, M. Fiocco, O. Mir, P. Rutkowski, J. Blay, P. Reichardt, H. Joensuu, E. Fumagalli, S. Gennatas, N. Hindi, M. Nannini, M. Spalato Ceruso, A. Italiano, G. Grignani, A. Brunello, S. Gasperoni, T. De Pas, G. Badalamenti, M.A. Pantaleo, W.J. van Houdt, N.S. Ijzerman, N. Steeghs, H. Gelderblom, I.M.E. Desar, J. Falkenhorst, M. Silletta, M. Sbaraglia, G. Tonini, J. Martin-Broto, P. Hohenberger, A. Le Cesne, R.L. Jones, A.P. Dei Tos, A. Gronchi, S. Bauer, P.G. Casali
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors
2020 R. Sanfilippo, C. Fabbroni, G. Fucà, E. Fumagalli, C. Morosi, M. Sbaraglia, A. Gronchi, P. Collini, A.P. Dei Tos, P.G. Casali
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
2020 G. Fucà, C. Fabbroni, R. Mancari, S. Manglaviti, G. Bogani, E. Fumagalli, R. Bertulli, C. Morosi, P. Collini, F. Raspagliesi, N. Colombo, P.G. Casali, R. Sanfilippo
Management of complicated tumor response to tyrosine-kinase inhibitors in gastrointestinal stromal tumors
2019 F. Tirotta, E. Fumagalli, C. Colombo, C. Morosi, M. Barisella, S. Radaelli, A.M. Frezza, P.G. Casali, A. Gronchi, M. Fiore
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma : A Multicenter, International, Retrospective Study
2019 G. Fucà, N. Hindi, I. Ray-Coquard, V. Colia, A.P. Dei Tos, J. Martin-Broto, M. Brahmi, P. Collini, D. Lorusso, F. Raspagliesi, M.A. Pantaleo, B. Vincenzi, E. Fumagalli, A. Gronchi, P.G. Casali, R. Sanfilippo
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST
2019 M. Urbini, V. Indio, G. Tarantino, G. Ravegnini, S. Angelini, M. Nannini, M. Saponara, D. Santini, C. Ceccarelli, M. Fiorentino, B. Vincenzi, E. Fumagalli, P.G. Casali, G. Grignani, A. Pession, A. Ardizzoni, A. Astolfi, M.A. Pantaleo
Role of chemotherapy, VEGFR inhibitors and mTOR Inhibitors in advanced Perivascular Epithelioid Cell Tumours (PEComas)
2019 R. Sanfilippo, R.L. Jones, J. Blay, A. Le Cesne, S. Provenzano, G. Antoniou, O. Mir, G. Fucà, E. Fumagalli, R. Bertulli, S. Stacchiotti, M. Brahmi, F. Grosso, A. Dufresne, N. Hindi, M. Sbaraglia, A. Gronchi, P. Collini, A.P. Dei Tos, P.G. Casali
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
2018 B. Vincenzi, M. Nannini, G. Badalamenti, G. Grignani, E. Fumagalli, S. Gasperoni, L. D’Ambrosio, L. Incorvaia, M. Stellato, M. Spalato Ceruso, A. Napolitano, S. Valeri, D. Santini, G. Tonini, P.G. Casali, A.P. Dei Tos, M.A. Pantaleo
Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma
2017 V. Colia, M. Fiore, S. Provenzano, E. Fumagalli, R. Bertulli, C. Morosi, A.P. Dei Tos, M. Barisella, A. Gronchi, P.G. Casali, R. Sanfilippo
High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma
2017 V. Colia, E. Fumagalli, S. Provenzano, R. Bertulli, S. Stacchiotti, C. Morosi, P. Collini, A. Gronchi, P.G. Casali, R. Sanfilippo
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST
2017 M.A. Pantaleo, M. Urbini, V. Indio, G. Ravegnini, M. Nannini, M. De Luca, G. Tarantino, S. Angelini, A. Gronchi, B. Vincenzi, G. Grignani, C. Colombo, E. Fumagalli, L. Gatto, M. Saponara, M. Ianni, P. Paterini, D. Santini, M.G. Pirini, C. Ceccarelli, A. Altimari, E. Gruppioni, S.L. Renne, P. Collini, S. Stacchiotti, G. Brandi, P.G. Casali, A.D. Pinna, A. Astolfi, G. Biasco
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice
2017 M. Nannini, M.C. Nigro, B. Vincenzi, E. Fumagalli, G. Grignani, L. D’Ambrosio, G. Badalamenti, L. Incorvaia, R. Bracci, S. Gasperoni, M. Saponara, L. Gatto, V. Indio, A. Astolfi, V. Di Scioscio, P.G. Casali, G. Tonini, M. Aglietta, A. Russo, G. Biasco, M.A. Pantaleo
Ten-year progression-free and overall survival in patients with unresectable or metastatic GI stromal tumors : long-term analysis of the european organisation for research and treatment of cancer, Italian sarcoma group, and Australasian gastrointestinal trials group intergroup phase III randomized trial on imatinib at two dose levels
2017 P.G. Casali, J. Zalcberg, A. Le Cesne, P. Reichardt, J.Y. Blay, L.H. Lindner, I.R. Judson, P. Schöffski, S. Leyvraz, A. Italiano, V. Grünwald, A. Lopez Pousa, D. Kotasek, S. Sleijfer, J.M. Kerst, P. Rutkowski, E. Fumagalli, P. Hogendoorn, S. Litière, S. Marreaud, W. van der Graaf, A. Gronchi, J. Verweij
High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
2014 R. Sanfilippo, R. Bertulli, A. Marrari, E. Fumagalli, S. Pilotti, C. Morosi, A. Messina, A.P. Dei Tos, A. Gronchi, P.G. Casali
Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib
2013 E. Conca, C. Miranda, V. Dal Col, E. Fumagalli, G. Pelosi, M. Mazzoni, M. Fermeglia, E. Laurini, A. Pierotti, S. Pilotti, A. Greco, S. Pricl, E. Tamborini
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake
2008 S. Colleoni, A.A. Jensen, E. Landucci, E. Fumagalli, P. Conti, A. Pinto, M. De Amici, D.E. Pellegrini Giampietro, C. De Micheli, T. Mennini, M. Gobbi
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?
2008 F. Miselli, T. Negri, A. Gronchi, M. Losa, E. Conca, S. Brich, E. Fumagalli, M. Fiore, P.G. Casali, M.A. Pierotti, E. Tamborini, S. Pilotti
Imatinib mesylate in chordoma
2004 P.G. Casali, A. Messina, S. Stacchiotti, E. Tamborini, F. Crippa, A. Gronchi, R. Orlandi, C. Ripamonti, C. Spreafico, R. Bertieri, R. Bertulli, M. Colecchia, E. Fumagalli, A. Greco, F. Grosso, P. Olmi, M.A. Pierotti, S. Pilotti